Table 3 assesses the changes in the prevalence of the different values of the insulin resistance and non-alcoholic fatty liver scales analyzed pre-lockdown and post-lockdown due to the COVID-19 pandemic, revealing statistically significant results with a difference of more than 2% between the years before and after pandemic in both groups as well as between patients with type 2 diabetes and non-diabetic patients. The gene discussed is INS; the disease is type 2 diabetes mellitus.